| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |